Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Co-presentation with both ANCA and anti-GBM antibodies is thought to be relatively rare. Current studies of such ‘double-positive’ cases report small numbers and variable outcomes. To study this further we retrospectively analyzed clinical features and long-term outcomes of a large cohort of 568 con...

Descripción completa

Detalles Bibliográficos
Autores principales: McAdoo, Stephen P., Tanna, Anisha, Hrušková, Zdenka, Holm, Lisa, Weiner, Maria, Arulkumaran, Nishkantha, Kang, Amy, Satrapová, Veronika, Levy, Jeremy, Ohlsson, Sophie, Tesar, Vladimir, Segelmark, Mårten, Pusey, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567410/
https://www.ncbi.nlm.nih.gov/pubmed/28506760
http://dx.doi.org/10.1016/j.kint.2017.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567410/
https://www.ncbi.nlm.nih.gov/pubmed/28506760
http://dx.doi.org/10.1016/j.kint.2017.03.014

Ejemplares similares